Eric Fung, Simon Shorter, Bjrn Ekstrm, John Murphy, Robert Friel, John Roush, Douglas Obenshain, Mor Amitai | GenomeWeb

Eric Fung has been promoted within Ciphergen’s diagnostic division to vice president of clinical and medical affairs. In his new position, Fung will manage biomarker discovery efforts within academic collaborations and direct clinical trial studies designed to achieve commercialization, the company said.

Ciphergen has also appointed Simon Shorter as vice president of business development. In his position, Shorter will oversee corporate strategy and academic business development activities, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.